• Morgan Stanley projects the "One Big Beautiful Bill" may widen deficits without delivering meaningful growth.
  • Tax cuts largely extend existing policies, while Medicaid reductions could dampen GDP over time.
  • Senate negotiations before the July 4 deadline may alter the bill's fiscal impact.

Fiscal Drag Looms Over Trump's Signature Bill

Morgan Stanley has cast doubt on the economic upside of President Trump's sweeping "One Big Beautiful Bill," arguing the legislation risks becoming a medium-term growth headwind despite administration claims of an economic "supercharge." The bank's analysis, circulated to clients this week, highlights how the bill's centerpiece tax provisions primarily perpetuate 2017 cuts rather than inject fresh stimulus.

While the House-passed version promises $7,800-$13,300 in average household income gains through permanent tax cuts and expanded credits, Morgan Stanley's team notes these figures assume optimistic growth scenarios. More concerning, analysts say, are proposed Medicaid reductions that could shave 0.2-0.4% off GDP annually after 2026. "The math simply doesn't support claims of transformative growth," said one executive familiar with the report, speaking anonymously because the analysis isn't public.

The Senate's Pivotal Role

With Senate negotiators racing toward a July 4 vote, key moderates are pushing to soften Medicaid cuts that Morgan Stanley flagged as economically hazardous. Banking sources confirm lobbyists are swarming Capitol Hill, with healthcare groups urging protections while business coalitions defend the 100% expensing provision for equipment purchases.

"This isn't 2017 when tax cuts were novel stimulus," noted a Morgan Stanley strategist. "Now you're making temporary policies permanent while cutting spending—that's a different calculus." The firm estimates the bill could add $2.8 trillion to deficits over a decade without commensurate growth, though Senate amendments might mitigate this.

Market Implications

Bond markets have shown muted reaction thus far, with 10-year Treasury yields holding near 4.3%. But some credit analysts warn that if the bill passes unchanged, rating agencies could revisit U.S. debt outlooks. "Deficit expansion without growth acceleration is the worst cocktail for long rates," said a fixed-income strategist at a rival bank.

[Updated 4:15 PM ET] This article has been revised to clarify Morgan Stanley's GDP impact estimates relate specifically to Medicaid provisions.